Jupiter Research Capital (Asia) Ltd’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Jupiter Research Capital (Asia) Ltd's PFE Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Pfizer (PFE) in Q3 2026, closing a stake of 49,553 shares — an estimated $1.19M sold.
Jupiter Research Capital (Asia) Ltd first reported a position in PFE in Q1 2026 and held it in 2 quarters. The position peaked at $2.79M in Q1 2026. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 49,553 Pfizer shares in Q3 2026, an estimated $1.19M.
- Jupiter Research Capital (Asia) Ltd first reported a position in Pfizer in Q1 2026 and held it in 2 quarters.
- Jupiter Research Capital (Asia) Ltd's Pfizer position peaked at $2.79M in Q1 2026.
- 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.